Market Place
Sourcing Support
Impax`s Generic Colesevelam Hydrochloride Receives Approval in the U.S.
18 Jan 2023 //
FDA
SPH`s Generic Colesevelam Hydrochloride Receives Approval in the U.S.
21 Jan 2022 //
FDA
Lupin`s Generic Colesevelam Hydrochloride Fumarate Receives Approval In US
21 Dec 2020 //
FDA
Inventia Healthcare Generic Colesevelam HCl Receives Approval in US
10 Dec 2020 //
FDA
Watson Lab`s Generic COLESEVELAM HYDROCHLORIDE Receives Approval In The US
13 Sep 2020 //
FDA
Zhejiang Jingxin`s Generic Colesevelam Hydrochloride Receives Approval In US
21 Jul 2020 //
FDA
Zhejiang Jingxin`s Generic Colesevelam Hydrochloride Receives Approval In US
18 Jul 2020 //
FDA
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
21 Jun 2019 //
FIERCE PHARMA
Alkem Labs Generic Colesevelam Hydrochloride Receives Approval in US
08 May 2019 //
FDA
Alkem Labs` Generic Colesevelam HydrochlorideReceives Approval in US
09 Oct 2018 //
FDA
Dr Reddys Labs` Generic Colesevelam HydrochlorideReceives Approval in US
09 Oct 2018 //
FDA
Impax Lab’s Generic Colesevelam HCl Receives Approval In US
21 May 2018 //
FDA
US Clearance of Goa Unit a Sales Boost for Lupin
08 Nov 2016 //
BUSINESS STANDARD
Daiichi Sankyo cashing out after merging Ranbaxy with Sun
21 Apr 2015 //
FIERCE PHARMA
Doctor Outreach at Heart of Daiichi Sankyo`s $39M Settlement with DoJ
17 Mar 2015 //
FIERCE PHARM ASIA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.